Literature DB >> 22826616

Edaravone inhibits apoptosis caused by ischemia/reperfusion injury in a porcine hepatectomy model.

Mitsugi Shimoda1, Yoshimi Iwasaki, Toshie Okada, Keiichi Kubota.   

Abstract

AIM: To investigate the effect of E3-methyl-1-phenyl-2-pyrazolin-5-one (Edr) on hepatic ischemia-reperfusion (I/R) injury and liver regeneration in a porcine hepatectomy model.
METHODS: One hour ischemia was induced by occluding the vessels and the bile duct of the right and median lobes. A 40% left hepatectomy was performed after reperfusion. Six animals received Edr (3 mg/kg per hour) intravenously and six control animals received saline just before reperfusion. Remnant liver volume, hemodynamics, aspartate aminotransferase (AST), alanine aminotransferase, lactate dehydrogenase and lactic acid, were compared between the groups. The expression of transforming growth factor-β (TGF-β1) and toll-like receptor (TRL) mRNA in hepatic tissues was examined using reverse transcription polymerase chain reaction. Apoptosis was demonstrated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, respectively.
RESULTS: Serum AST (P = 0.029), and toll like receptor 4 level (P = 0.043) were significantly lower after 3 h in animals receiving Edr. In addition, TUNEL staining in Edr-treated pigs showed significantly fewer hepatocytes undergoing apoptosis compared with control pigs. After 1 mo, all factors were non-significantly different between the two groups.
CONCLUSION: Edr is considered to reduce hepatic injury in the early stage of I/R injury in a porcine model.

Entities:  

Keywords:  Edaravone; Ischemia-reperfusion injury; Liver resection; Toll like receptor 4; Transforming growth factor-β

Mesh:

Substances:

Year:  2012        PMID: 22826616      PMCID: PMC3400853          DOI: 10.3748/wjg.v18.i27.3520

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Safety of hemihepatic vascular occlusion during resection of the liver.

Authors:  M Makuuchi; T Mori; P Gunvén; S Yamazaki; H Hasegawa
Journal:  Surg Gynecol Obstet       Date:  1987-02

2.  Serum contains a platelet-derived transforming growth factor.

Authors:  C B Childs; J A Proper; R F Tucker; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

3.  Effects of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular carcinoma.

Authors:  K Hanazaki; S Kajikawa; Y Fujimori; S Nakata; N Shimozawa; N Koide; W Adachi; J Amano
Journal:  Hepatogastroenterology       Date:  2000 Mar-Apr

4.  Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.

Authors:  H Kawai; H Nakai; M Suga; S Yuki; T Watanabe; K I Saito
Journal:  J Pharmacol Exp Ther       Date:  1997-05       Impact factor: 4.030

5.  Continuous versus intermittent portal triad clamping for liver resection: a controlled study.

Authors:  J Belghiti; R Noun; R Malafosse; P Jagot; A Sauvanet; F Pierangeli; J Marty; O Farges
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

Review 6.  Ischaemia-reperfusion injury.

Authors:  P A Grace
Journal:  Br J Surg       Date:  1994-05       Impact factor: 6.939

7.  Protective effect of Sivelestat in a porcine hepatectomy model prepared using an intermittent Pringle method.

Authors:  Mitsugi Shimoda; Yoshimi Iwasaki; Toshie Okada; Tokihiko Sawada; Keiichi Kubota
Journal:  Eur J Pharmacol       Date:  2008-02-29       Impact factor: 4.432

8.  Myocardial protection of MCI-186 in rabbit ischemia-reperfusion.

Authors:  Tai-Wing Wu; Ling-Hua Zeng; Jun Wu; Kwok-Pui Fung
Journal:  Life Sci       Date:  2002-09-27       Impact factor: 5.037

9.  Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions.

Authors:  T Watanabe; S Yuki; M Egawa; H Nishi
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

10.  Effect of intermittent hepatic pedicle clamping on free radical generation in the rat liver.

Authors:  M Uchinami; R Muraoka; T Horiuchi; T Tabo; N Kimura; Y Naito; T Yoshikawa
Journal:  Surgery       Date:  1998-07       Impact factor: 3.982

View more
  5 in total

Review 1.  Hepatic ischemia and reperfusion injury and trauma: current concepts.

Authors:  Dimitrios Papadopoulos; Thomas Siempis; Eleni Theodorakou; Georgios Tsoulfas
Journal:  Arch Trauma Res       Date:  2013-08-01

2.  Edaravone promotes functional recovery after mechanical peripheral nerve injury.

Authors:  Teng Zhang; Zhengwei Li; Jianli Dong; Feng Nan; Tao Li; Qing Yu
Journal:  Neural Regen Res       Date:  2014-09-15       Impact factor: 5.135

3.  A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion.

Authors:  Fausto Chiazza; Konstantin Chegaev; Mara Rogazzo; Juan C Cutrin; Elisa Benetti; Loretta Lazzarato; Roberta Fruttero; Massimo Collino
Journal:  Oxid Med Cell Longev       Date:  2015-03-05       Impact factor: 6.543

4.  Edaravone protects endotoxin-induced liver injury by inhibiting apoptosis and reducing proinflammatory cytokines.

Authors:  L Zong; Q H Yu; Y X Du; X M Deng
Journal:  Braz J Med Biol Res       Date:  2014-01-29       Impact factor: 2.590

5.  Laparoscopic left hepatectomy in swine: a safe and feasible technique.

Authors:  Hua Zhang; Tao Liu; Yue Wang; Hai-Feng Liu; Jian-Tao Zhang; Yan-Shuang Wu; Lei Lei; Hong-Bin Wang
Journal:  J Vet Sci       Date:  2014-06-20       Impact factor: 1.672

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.